Quarterly report pursuant to Section 13 or 15(d)

Schedule of Warrant Liability (Details)

v3.22.4
Schedule of Warrant Liability (Details) - $ / shares
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Initial Grants 190,479,262 225,792,614
Outstanding shares, beginning 160,701,887 197,596,456
Exercises 61,430,123 98,324,692
Outstanding shares, ending 99,271,764 99,271,764
Exercises (61,430,123) (98,324,692)
June [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Exercise Price [1] $ 3.3000 $ 3.3000
Initial Grants 29,893,175 29,893,175
Outstanding shares, beginning 115,800 20,386,206
Exercises 20,270,406
Outstanding shares, ending 115,800 115,800
Exercises (20,270,406)
September A [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Exercise Price [1] $ 9.0000 $ 9.0000
Initial Grants 21,600,000 21,600,000
Outstanding shares, beginning 21,600,000 21,600,000
Exercises 15,000,000 15,000,000
Outstanding shares, ending 6,600,000 6,600,000
Exercises (15,000,000) (15,000,000)
November [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Exercise Price [1] $ 4.5270 $ 4.5270
Initial Grants 16,200,000 16,200,000
Outstanding shares, beginning 16,200,000 16,200,000
Exercises 500,000 500,000
Outstanding shares, ending 15,700,000 15,700,000
Exercises (500,000) (500,000)
December [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Exercise Price [1] $ 3.2653 $ 3.2653
Initial Grants 122,786,087 122,786,087
Outstanding shares, beginning 122,786,087 122,786,087
Exercises 45,930,123 45,930,123
Outstanding shares, ending 76,855,964 76,855,964
Exercises (45,930,123) (45,930,123)
July [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Exercise Price [1]   $ 2.6550
Initial Grants   35,313,352
Outstanding shares, beginning   16,624,163
Exercises   16,624,163
Outstanding shares, ending
Exercises   (16,624,163)
[1] Based on Exercise Price as of the initial grant; the above disclosure discusses modifications under specific Warrant Exchange Agreements.